282 related articles for article (PubMed ID: 18657610)
1. In vivo assessment of safety of microneedle arrays in human skin.
Bal SM; Caussin J; Pavel S; Bouwstra JA
Eur J Pharm Sci; 2008 Oct; 35(3):193-202. PubMed ID: 18657610
[TBL] [Abstract][Full Text] [Related]
2. Evaluation needle length and density of microneedle arrays in the pretreatment of skin for transdermal drug delivery.
Yan G; Warner KS; Zhang J; Sharma S; Gale BK
Int J Pharm; 2010 May; 391(1-2):7-12. PubMed ID: 20188808
[TBL] [Abstract][Full Text] [Related]
3. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
4. Assembled microneedle arrays enhance the transport of compounds varying over a large range of molecular weight across human dermatomed skin.
Verbaan FJ; Bal SM; van den Berg DJ; Groenink WH; Verpoorten H; Lüttge R; Bouwstra JA
J Control Release; 2007 Feb; 117(2):238-45. PubMed ID: 17196697
[TBL] [Abstract][Full Text] [Related]
5. Facial skin barrier function recovery after microneedle transdermal delivery treatment.
Han TY; Park KY; Ahn JY; Kim SW; Jung HJ; Kim BJ
Dermatol Surg; 2012 Nov; 38(11):1816-22. PubMed ID: 22882208
[TBL] [Abstract][Full Text] [Related]
6. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.
Vicente-Perez EM; Larrañeta E; McCrudden MTC; Kissenpfennig A; Hegarty S; McCarthy HO; Donnelly RF
Eur J Pharm Biopharm; 2017 Aug; 117():400-407. PubMed ID: 28478160
[TBL] [Abstract][Full Text] [Related]
7. Transdermal delivery of insulin using microneedle rollers in vivo.
Zhou CP; Liu YL; Wang HL; Zhang PX; Zhang JL
Int J Pharm; 2010 Jun; 392(1-2):127-33. PubMed ID: 20347024
[TBL] [Abstract][Full Text] [Related]
8. Clinical microneedle injection of methyl nicotinate: stratum corneum penetration.
Sivamani RK; Stoeber B; Wu GC; Zhai H; Liepmann D; Maibach H
Skin Res Technol; 2005 May; 11(2):152-6. PubMed ID: 15807814
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the effect of polymeric microneedle arrays of varying geometries in combination with a high-velocity applicator on skin permeability and irritation.
Watanabe T; Hagino K; Sato T
Biomed Microdevices; 2014 Aug; 16(4):591-7. PubMed ID: 24733417
[TBL] [Abstract][Full Text] [Related]
10. Microneedle-based drug delivery: studies on delivery parameters and biocompatibility.
Wu Y; Qiu Y; Zhang S; Qin G; Gao Y
Biomed Microdevices; 2008 Oct; 10(5):601-10. PubMed ID: 18324474
[TBL] [Abstract][Full Text] [Related]
11. Effect of microneedle design on pain in human volunteers.
Gill HS; Denson DD; Burris BA; Prausnitz MR
Clin J Pain; 2008 Sep; 24(7):585-94. PubMed ID: 18716497
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of the invasiveness of polymer microneedle against skin.
Noh YW; Kim TH; Baek JS; Park HH; Lee SS; Han M; Shin SC; Cho CW
Int J Pharm; 2010 Sep; 397(1-2):201-5. PubMed ID: 20619328
[TBL] [Abstract][Full Text] [Related]
13. Enhanced skin delivery of vismodegib by microneedle treatment.
Nguyen HX; Banga AK
Drug Deliv Transl Res; 2015 Aug; 5(4):407-23. PubMed ID: 26069156
[TBL] [Abstract][Full Text] [Related]
14. Microneedles for transdermal drug delivery.
Prausnitz MR
Adv Drug Deliv Rev; 2004 Mar; 56(5):581-7. PubMed ID: 15019747
[TBL] [Abstract][Full Text] [Related]
15. Optimizing microneedle arrays to increase skin permeability for transdermal drug delivery.
Al-Qallaf B; Das DB
Ann N Y Acad Sci; 2009 Apr; 1161():83-94. PubMed ID: 19426308
[TBL] [Abstract][Full Text] [Related]
16. Parameter optimization toward optimal microneedle-based dermal vaccination.
van der Maaden K; Varypataki EM; Yu H; Romeijn S; Jiskoot W; Bouwstra J
Eur J Pharm Sci; 2014 Nov; 64():18-25. PubMed ID: 25151530
[TBL] [Abstract][Full Text] [Related]
17. Microneedle-based drug and vaccine delivery via nanoporous microneedle arrays.
van der Maaden K; Luttge R; Vos PJ; Bouwstra J; Kersten G; Ploemen I
Drug Deliv Transl Res; 2015 Aug; 5(4):397-406. PubMed ID: 26044672
[TBL] [Abstract][Full Text] [Related]
18. A simple method of microneedle array fabrication for transdermal drug delivery.
Kochhar JS; Goh WJ; Chan SY; Kang L
Drug Dev Ind Pharm; 2013 Feb; 39(2):299-309. PubMed ID: 22519721
[TBL] [Abstract][Full Text] [Related]
19. Development of a drug-coated microneedle array and its application for transdermal delivery of interferon alpha.
Kusamori K; Katsumi H; Sakai R; Hayashi R; Hirai Y; Tanaka Y; Hitomi K; Quan YS; Kamiyama F; Yamada K; Sumida S; Kishi K; Hashiba K; Sakane T; Yamamoto A
Biofabrication; 2016 Jan; 8(1):015006. PubMed ID: 26756832
[TBL] [Abstract][Full Text] [Related]
20. Rapid local anesthesia in humans using minimally invasive microneedles.
Gupta J; Denson DD; Felner EI; Prausnitz MR
Clin J Pain; 2012 Feb; 28(2):129-35. PubMed ID: 21712713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
